Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Onesource Specialty Pharma Ltd
Press Release Apr 21 2026
Business
Apr 21 2026
4 min read

Press Release Apr 21 2026

Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated April 21, 2026, titled "Orbicular s Partner secures tentative U.S. ANDA approval for a generic version of Ozempic® (Semaglutide Injection), supported by OneSource as CDMO partner".

View Attachment